News
-
Menopause-depression
Tuesday | Dec 4 2018PERIMENOPAUSAL depression contributes to the high rate of suicide in women aged 45--54 years, according to an article in this month's Australian Prescriber.
-
Dispensary Corner
Tuesday | Dec 4 2018
04 Dec 18PARACETAMOL has a whole new market, but its status as a generic may mean there is no bonanza for any one manufacturer.
-
-
PD breaking news – MedAdvisor forms Asia joint venture with Zuellig Pharma
Monday | Dec 3 2018Singapore-based JV to commercialise MedAdvisor platform under exclusive licence for Asia.
-
New Raven’s salary report
Monday | Dec 3 2018EMPLOYMENT opportunities remain strong within the community and hospital pharmacy sectors, with shortages of skilled pharmacists leading to wage growth in both metropolitan and regional areas.
-
Direct supply CSO squeeze
Monday | Dec 3 2018TENDER documents for the Community Service Obligation (CSO) issued on Fri have confirmed that controversial exclusive direct supply arrangements for some medications will continue - but such distributors will not be able to access the CSO Funding Pool.
-
Phebra phosphate
Monday | Dec 3 2018PHEBRA has announced the launch of its own brand of Phosphate 500mg effervescent tablets to replace the discontinued Phosphate Sandoz (Novartis generics) product.
-
Rare cancer drug PBS
Monday | Dec 3 2018FEDERAL Health Minister Greg Hunt last week announced an additional treatment option, Somatuline Autogel (lanreotide) from Ipsen will be listed on the Pharmaceutical Benefits Scheme for patients with a rare type of cancer, known as GEP-NETs or as gastroenteropancreatic neuroendocrine tumours.
-
Boxed warning update
Monday | Dec 3 2018THE Therapeutic Goods Administration (TGA) has published a comprehensive document clarifying the purpose of Boxed Warnings in Product Information (PI) or Consumer Medicine Information (CMI) documents, along with guidance on how and when to use them.
-
Measles resurgence
Monday | Dec 3 2018THE World Health Organization (WHO) data shows a rise in cases in almost every region of the world, with 30% more cases in 2017 than 2016, attributing it to "hesitancy" around vaccination.
